White Paper: Beyond the Promise of Artificial Intelligence in Electronic Benefit Verification

By Lash Group | January 22, 2020

Insights Home

AI-powered eBV represents a potent mix of human and machine that could positively impact every stakeholder in the pharma continuum. Manufacturers who make the most of that balance with optimal tech choices will have the competitive advantage.

Download our new white paper to learn how to optimize eBV with AI and machine learning.
You'll gain:
- Insights into the differences between logic-based and AI-based approaches for
benefit verification
- Leading-edge innovations and technologies that push what's possible for eBV
- How to evaluate and scale potential solutions for your unique needs

Enter Your Information to Access the White Paper

                                                First Name
    Last Name
    Company
    Email Address
    Title
Country*



    By submitting this form, I hereby consent to the receipt of marketing materials from
AmerisourceBergen and its affiliates via email and other forms of communications.

Topics:

Commercialization Patient Support Services Product Access Technology

White Paper: Beyond the Promise of Artificial Intelligence in Electronic Benefit Verification

By Lash Group | January 22, 2020

Enter Your Information to Access the White Paper

Related Content

Harnessing the power of a digital assistant to accelerate patient access

Webinar Part 2: Leveraging AI within eBV to speed access to therapy

Simplifying the Path to Better Patient Outcomes